Inflammatory Intestinal Diseases

Código QR

Inflammatory Intestinal Diseases

Guardado en:

Detalles Bibliográficos
Formato:	journal
Lenguaje:	EN
Publicado:	Karger Publishers 2020
Materias:	gastroenterology inflammatory bowel disease colitis chron's disease irritable bowel syndrome intestinal tract Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/toc/2296-9365
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021)

Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices
por: Rohan V Yewale, et al.
Publicado: (2021)

Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review
por: Duc Trong Quach, et al.
Publicado: (2021)

Positioning Aeromonas Infection in Inflammatory Bowel Disease: A Retrospective Analysis
por: Tiago Pereira Guedes, et al.
Publicado: (2021)

Screening for Celiac Disease in Patients with Irritable Bowel Syndrome Fulfilling Rome III Criteria
por: Khaldoon Thanoon Al-Abachi
Publicado: (2021)

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Gwen M. C. Masclee, et al.
Publicado: (2021)

Intrarectal Xyloglucan Administration Reduces Disease Severity in the Dextran Sodium Sulfate Model of Mouse Colitis
por: Ross EA, et al.
Publicado: (2021)

Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
por: Yusuke Yasutomi, et al.
Publicado: (2022)

Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile
por: Harish Chandra, et al.
Publicado: (2021)

Endoscopy Capsule Retention in a Young Female with Small Bowel Strictures Secondary to Non-Steroidal Anti-Inflammatory Drugs
por: Muhammad Umair Tayyub, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Gianluca Ianiro, et al.
Publicado: (2021)

E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis
por: Louis C Dacquay, et al.
Publicado: (2021)

Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn’s disease
por: Xu Zhilu, et al.
Publicado: (2021)

The Evolution of Very Early Onset Inflammatory Bowel Disease, Autoimmune Hepatitis, and Primary Sclerosing Cholangitis in a Young Girl
por: Aditi Dey, et al.
Publicado: (2021)

Brown Bowel Syndrome: An Exceedingly Rare Condition with Longstanding Malabsorption and an Unusual Cause of Colon Pseudo-Obstruction
por: Adnan Alkurdi, et al.
Publicado: (2021)

Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
por: Christine Beran, et al.
Publicado: (2021)

Evaluation of the Clinical Effects and Frequency of MEFV Gene Mutation in Patients with Inflammatory Bowel Disease
por: S. Sahin, et al.
Publicado: (2021)

DEDICATED PSYCHIATRY CLINIC FOR INFLAMMATORY BOWEL DISEASE PATIENTS HAS A POSITIVE IMPACT ON DEPRESSION SCORES
por: Kaleb Bogale, et al.
Publicado: (2021)

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
por: Mohammad Shehab, et al.
Publicado: (2021)

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
por: Peter M Irving, et al.
Publicado: (2021)

Meckel’s Diverticulum Diagnosed by Balloon-Assisted Enteroscopy: A Multicenter Report from the Taiwan Association for the Study of Small Intestinal Diseases (TASSID)
por: Jen-Wei Chou, et al.
Publicado: (2021)

Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
por: Manasvini Markandey, et al.
Publicado: (2021)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic
por: Henit Yanai, et al.
Publicado: (2021)

In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

Rebuttal to: In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

Autonomic dysfunction in chronic liver disease
por: Frith J, et al.
Publicado: (2011)

Review of exclusive enteral therapy in adult Crohn’s disease
por: Nikola Mitrev, et al.
Publicado: (2021)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease
por: Bradford V, et al.
Publicado: (2013)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt SJ, et al.
Publicado: (2014)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka M, et al.
Publicado: (2015)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau T, et al.
Publicado: (2013)

Cricopharyngeal peroral endoscopic myotomy improves oropharyngeal dysphagia in patients with Parkinson’s disease
por: Peter I. Wu, et al.
Publicado: (2021)

Association between hepatic fat and subclinical vascular disease burden in the general population
por: Susanne Rospleszcz, et al.
Publicado: (2021)

Clinical features and prognosis of primary myelofibrosis with hepatic vascular disease and/or portal hypertension
por: WANG Jing
Publicado: (2021)

Prevalence rate of non-obese fatty liver disease and related influencing factors
por: DENG Jiang
Publicado: (2021)

Do gastroenterologists have medical inertia towards coeliac disease? A UK multicentre secondary care study
por: Hugo A Penny, et al.
Publicado: (2021)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021)

Association between liver fibrosis progression and endothelin-1/nitric oxide in patients with nonalcoholic fatty liver disease
por: LI Pinhua
Publicado: (2021)